DK144093D0 - - Google Patents
Info
- Publication number
- DK144093D0 DK144093D0 DK144093A DK144093A DK144093D0 DK 144093 D0 DK144093 D0 DK 144093D0 DK 144093 A DK144093 A DK 144093A DK 144093 A DK144093 A DK 144093A DK 144093 D0 DK144093 D0 DK 144093D0
- Authority
- DK
- Denmark
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK144093A DK144093D0 (ru) | 1993-12-23 | 1993-12-23 | |
| PCT/DK1994/000487 WO1995017510A1 (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
| AU12725/95A AU1272595A (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK144093A DK144093D0 (ru) | 1993-12-23 | 1993-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK144093D0 true DK144093D0 (ru) | 1993-12-23 |
Family
ID=8104857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK144093A DK144093D0 (ru) | 1993-12-23 | 1993-12-23 |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1272595A (ru) |
| DK (1) | DK144093D0 (ru) |
| WO (1) | WO1995017510A1 (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
| US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
| CN1162446C (zh) * | 2001-05-10 | 2004-08-18 | 上海华谊生物技术有限公司 | 促胰岛素分泌肽衍生物 |
| CN1363654A (zh) * | 2001-07-19 | 2002-08-14 | 上海华谊生物技术有限公司 | 生产促胰岛素分泌肽glp－1(7－36)的基因工程菌以及生产glp－1(7－36)的方法 |
| EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
| WO2003099848A2 (en) | 2002-05-24 | 2003-12-04 | Restoragen Inc. | Method for universal enzymatic production of bioactive peptides |
| WO2003099854A2 (en) | 2002-05-24 | 2003-12-04 | Nps Allelix Corp. | Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| AU2003239863A1 (en) * | 2002-05-24 | 2003-12-12 | Restoragen Inc. | Method for enzymatic production of glp-1 (7-36) amide peptides |
| SI1704234T1 (sl) | 2003-11-21 | 2012-08-31 | Nps Pharma Inc | Proizvodnja glukagonu podobnih peptidov 2 in analogov |
| EP1729795B1 (en) * | 2004-02-09 | 2016-02-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| CN100429227C (zh) | 2005-06-29 | 2008-10-29 | 常州制药厂有限公司 | Exendin4多肽片段 |
| EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
| WO2016210384A2 (en) | 2015-06-25 | 2016-12-29 | Synlogic, Inc. | Bacteria engineered to treat metabolic diseases |
| WO2017139708A1 (en) | 2016-02-10 | 2017-08-17 | Synlogic, Inc. | Bacteria engineered to treat nonalcoholic steatohepatitis (nash) |
| US20200024321A1 (en) | 2017-03-20 | 2020-01-23 | Lupin Limited | Expression and large-scale production of peptides |
| CN113846124A (zh) * | 2021-09-26 | 2021-12-28 | 康霖生物科技（杭州）有限公司 | 一种用于糖代谢相关疾病基因治疗的核酸构建体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK27885A (da) * | 1985-01-22 | 1986-07-23 | Novo Industri As | Fremstilling af peptider |
| US5118666A (en) * | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| AU4216689A (en) * | 1988-08-11 | 1990-03-05 | California Biotechnology, Inc. | Method for stabilizing heterologous protein expression and vectors for use therein |
| ATE164852T1 (de) * | 1990-01-24 | 1998-04-15 | Douglas I Buckley | Glp-1-analoga verwendbar in der diabetesbehandlung |
| US5202239A (en) * | 1990-08-07 | 1993-04-13 | Scios Nova Inc. | Expression of recombinant polypeptides with improved purification |
-
1993
- 1993-12-23 DK DK144093A patent/DK144093D0/da not_active Application Discontinuation
-
1994
- 1994-12-22 AU AU12725/95A patent/AU1272595A/en not_active Abandoned
- 1994-12-22 WO PCT/DK1994/000487 patent/WO1995017510A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| AU1272595A (en) | 1995-07-10 |
| WO1995017510A1 (en) | 1995-06-29 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| ATS | Application withdrawn |